Show simple item record

dc.contributor.authorForrest, EH
dc.contributor.authorAtkinson, SR
dc.contributor.authorRichardson, P
dc.contributor.authorMasson, S
dc.contributor.authorRyder, S
dc.contributor.authorThursz, MR
dc.contributor.authorAllison, M
dc.contributor.authorMcCune, A
dc.contributor.authorGleeson, D
dc.contributor.authorAustin, A
dc.contributor.authorPatch, D
dc.contributor.authorDhanda, A
dc.contributor.authorShawcross, D
dc.contributor.authorWright, M
dc.date.accessioned2018-10-23T23:34:56Z
dc.date.available2018-10-23T23:34:56Z
dc.date.issued2018-03
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.urihttp://hdl.handle.net/10026.1/12593
dc.descriptionpublisher: Elsevier articletitle: Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis journaltitle: Journal of Hepatology articlelink: http://dx.doi.org/10.1016/j.jhep.2017.11.017 content_type: article copyright: Crown Copyright © 2017 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver. All rights reserved.
dc.description.abstract

BACKGROUND & AIMS: 'Static' prognostic models in alcoholic hepatitis, using data from a single time point, include the discriminant function (DF), Glasgow alcoholic hepatitis score (GAHS), the age, serum bilirubin, international normalized ratio and serum creatinine (ABIC) score and the model of end-stage liver disease (MELD). 'Dynamic' scores, incorporating evolution of bilirubin at seven days, include the Lille score. The aim of this study was to assess these scores' performance in patients from the STOPAH trial. METHODS: Predictive performance of scores was assessed by area under the receiver operating curve (AUC). The effect of different therapeutic strategies upon survival was assessed by Kaplan-Meier analysis and tested using the log-rank test. RESULTS: A total of 1,068 patients were studied. The AUCs for the DF were significantly lower than for MELD, ABIC and GAHS for both 28- and 90-day outcomes: 90-day values were 0.670, 0.704, 0.726 and 0.713, respectively. 'Dynamic' scores and change in 'static' scores by Day 7 had similar AUCs. Patients with consistently low 'static' scores had low 28-day mortalities that were not improved with prednisolone (MELD <25: 8.6%; ABIC <6.71: 6.6%; GAHS <9: 5.9%). In patients with high 'static' scores without gastrointestinal bleeding or sepsis, prednisolone reduced 28-day mortality (MELD: 22.2% vs. 28.9%, p = 0.13; ABIC 14.6% vs. 21%, p = 0.02; GAHS 21% vs. 29.3%, p = 0.04). Overall mortality from treating all patients with a DF ≥32 and Lille assessment (90-day mortality 26.8%) was greater than combining newer 'static' and 'dynamic' scores (90-day mortality: MELD/Lille 21.8%; ABIC/Lille 23.7%; GAHS/Lille 20.6%). CONCLUSION: MELD, ABIC and GAHS are superior to the DF in alcoholic hepatitis. Consistently low scores have a favourable outcome not improved with prednisolone. Combined baseline 'static' and Day 7 scores reduce the number of patients exposed to corticosteroids and improve 90-day outcome. LAY SUMMARY: Alcoholic hepatitis is a life-threatening condition. Several scores exist to determine the outcome of these patients as well as to identify those who may benefit from treatment. This study looked at the performance of existing scores in patients who had been recruited to the largest alcoholic hepatitis clinical trial: STOPAH. 'Static' scores are calculable at the start of assessment. The three newer static scores (ABIC, GAHS and MELD) were shown to be superior to the oldest score (DF). ABIC and GAHS could also identify patients who had a survival benefit 28 days after starting prednisolone treatment. 'Dynamic' scores relate to the change in disease over the first week of treatment. Combination of the 'static' scores 'with the 'dynamic' scores or change in 'static' scores allowed identification of patients who could benefit from prednisolone up to 90 days.

dc.format.extent511-518
dc.format.mediumPrint-Electronic
dc.languageen
dc.language.isoen
dc.publisherElsevier
dc.subjectAlcoholic hepatitis
dc.subjectPrednisolone
dc.subjectPrognosis
dc.subjectABIC
dc.subjectGAHS
dc.subjectMELD
dc.subjectDiscriminant function
dc.titleApplication of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29175535
plymouth.issue3
plymouth.volume68
plymouth.publication-statusPublished
plymouth.journalJournal of Hepatology
dc.identifier.doi10.1016/j.jhep.2017.11.017
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR)
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeNetherlands
dcterms.dateAccepted2017-11-01
dc.rights.embargodate2018-11-21
dc.identifier.eissn1600-0641
dc.rights.embargoperiodNot known
rioxxterms.funderMedical Research Council
rioxxterms.identifier.projectMICA: Minimising Mortality from Alcoholic Hepatitis
rioxxterms.versionofrecord10.1016/j.jhep.2017.11.017
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-03
rioxxterms.typeJournal Article/Review
plymouth.funderMICA: Minimising Mortality from Alcoholic Hepatitis::Medical Research Council


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV